- Home
- CHNR vs DRMA Comparison
CHNR vs DRMA Comparison
Compare CHNR & DRMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CHNR
- DRMA
- Stock Information
- Founded
- CHNR N/A
- DRMA 2014
- Country
- CHNR Hong Kong
- DRMA United States
- Employees
- CHNR N/A
- DRMA N/A
- Industry
- CHNR Precious Metals
- DRMA Biotechnology: Pharmaceutical Preparations
- Sector
- CHNR Basic Materials
- DRMA Health Care
- Exchange
- CHNR Nasdaq
- DRMA Nasdaq
- Market Cap
- CHNR 4.8M
- DRMA 4.5M
- IPO Year
- CHNR 1995
- DRMA 2021
- Fundamental
- Price
- CHNR $0.57
- DRMA $0.75
- Analyst Decision
- CHNR
- DRMA Strong Buy
- Analyst Count
- CHNR 0
- DRMA 1
- Target Price
- CHNR N/A
- DRMA $6.00
- AVG Volume (30 Days)
- CHNR 13.5K
- DRMA 4.2M
- Earning Date
- CHNR 01-01-0001
- DRMA 05-14-2025
- Dividend Yield
- CHNR N/A
- DRMA N/A
- EPS Growth
- CHNR N/A
- DRMA N/A
- EPS
- CHNR N/A
- DRMA N/A
- Revenue
- CHNR N/A
- DRMA N/A
- Revenue This Year
- CHNR N/A
- DRMA N/A
- Revenue Next Year
- CHNR N/A
- DRMA N/A
- P/E Ratio
- CHNR N/A
- DRMA N/A
- Revenue Growth
- CHNR N/A
- DRMA N/A
- 52 Week Low
- CHNR $0.45
- DRMA $0.69
- 52 Week High
- CHNR $1.14
- DRMA $6.17
- Technical
- Relative Strength Index (RSI)
- CHNR 55.22
- DRMA 34.82
- Support Level
- CHNR $0.45
- DRMA $0.69
- Resistance Level
- CHNR $0.55
- DRMA $0.85
- Average True Range (ATR)
- CHNR 0.05
- DRMA 0.08
- MACD
- CHNR 0.01
- DRMA -0.00
- Stochastic Oscillator
- CHNR 78.20
- DRMA 21.43
About CHNR China Natural Resources Inc.
China Natural Resources Inc is an investment holding company. It principally engaged in the exploration and mining and wastewater treatment businesses in the People's Republic of China. The company has two operating segments: (i) Wastewater treatment segment, which consists of sales of assembled equipment, provision of construction service, and participation in PPP projects as an operator (ii) Exploration and mining segment, which consists of the exploration of lead, silver, and other metals in the Inner Mongolia Autonomous Region of the PRC and the trading of copper ores products. It earns the majority of its revenue from the Wastewater treatment segment.
About DRMA Dermata Therapeutics Inc.
Dermata Therapeutics Inc. is a clinical-stage medical dermatology company focused on identifying, developing, and commercializing pharmaceutical product candidates for the treatment of medical and aesthetic skin conditions and diseases. Its two product candidates, DMT310 and DMT410, incorporate its proprietary, multifaceted, Spongilla technology to topically treat a variety of dermatological conditions. Its Spongilla technology platform will enable to development and formulation of singular and combination products that can target topical delivery of chemical compounds into the dermis for maximum treatment effect for a variety of inflammatory skin diseases.